FHL1 and cardiomyopathy: Collectively, the JAK-STAT pathway may signal to reduce the transcriptional activity of EP300 (i.e., increased T887 phosphorylation) and the expression of FHL1/SLIM, which is implicated in protein turnover and cardiomyopathy [59, 60].